Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
03/24/2005 | WO2004046162A8 Non-steroidal fxr agonists |
03/24/2005 | WO2004041161A3 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
03/24/2005 | WO2004039795A3 Amide compounds for the treatment of hyperlipidemia |
03/24/2005 | US20050065201 Fungicides in human, animals; controlling plant diseases; reacting 1-(2,4-dichlorophenyl)-2-imidazol-1-yl-ethanol with halogen substituted benzthiophene compoundu |
03/24/2005 | US20050065186 Heterocyclyloxy-, -thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
03/24/2005 | US20050065185 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
03/24/2005 | US20050065163 Platelet adenosine diphosphate receptor antagonists |
03/24/2005 | US20050065150 Lipoxygenase moderators; autoimmune disease; neurodegenerative disease; respiratory system disorders; cardiovascular disorders; Alzheimer's disease; Parkinson's disease; amyotropic lateral sclerosis |
03/24/2005 | US20050065149 Neurodegenerative disorders; antiinflammatory agents; strokes; antiischemic agents; neuropathic pain; brain disorders; antiepileptic agents; Parkinson's disease ; amyotropic lateral sclerosis; Alzheimer's disease; antidiabetic agents |
03/24/2005 | US20050065148 Dipeptidyl peptidase inhibitors |
03/24/2005 | US20050065099 Treatment of mitochondrial diseases |
03/24/2005 | US20050064415 Novel terthiophene-3-carboxylic acid compound and fabricating method thereof, functionalized conductive terthiophene polymer with the compound as a monomer, process for dna hybridizatioon detection using the polymer, and fabricating method of probe dna |
03/24/2005 | US20050064333 polymerization catalysts such as 5-(2,4-dimethylphenyl) thianthrenium hexafluoroantimonate, used for polymerization of epoxy and vinyl ether monomers |
03/24/2005 | CA2538552A1 Pyrrol derivatives with antibacterial activity |
03/24/2005 | CA2536633A1 Fused ring heterocycles as potassium channel modulators |
03/23/2005 | EP1516877A1 Amine derivatives as protease inhibitors |
03/23/2005 | EP1516875A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
03/23/2005 | EP1516874A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
03/23/2005 | EP1515964A1 Substituted diaminopyrimidines |
03/23/2005 | EP1515953A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
03/23/2005 | EP1515951A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors |
03/23/2005 | EP1515944A1 Aspartyl protease inhibitors |
03/23/2005 | EP1515724A1 Mitotic kinesin inhibitors |
03/23/2005 | EP1515722A2 Ophthalmic compositions for treating ocular hypertension |
03/23/2005 | EP1515721A1 Ophthalmic compositions for treating ocular hypertension |
03/23/2005 | EP1427725B1 Pyrazolyl-substituted thienyloxypyridines |
03/23/2005 | EP1105120B1 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION |
03/23/2005 | CN1599734A 3, 4-di-substituted maleimide compounds as CXC-chemokine receptor antagonists |
03/23/2005 | CN1599733A N-ureido-piperidines as antagonists viii for CCR-3 receptor |
03/23/2005 | CN1599729A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
03/23/2005 | CN1599724A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity |
03/23/2005 | CN1599722A 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
03/23/2005 | CN1599718A Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
03/23/2005 | CN1599717A Cyclic diamine compounds having fused-ring groups |
03/23/2005 | CN1599607A Carbinols for the treatment of neuropathic dysfunction |
03/23/2005 | CN1597680A New method of synthesizing thalidomide and its derivative |
03/23/2005 | CN1597677A Compounds and methods for modulation of estrogen receptors |
03/22/2005 | US6870055 Heterocyclic amides such as 3-dimethylaminomethyl-6-methoxy-2 -methyl-4-phenyl-2H-isoquinoline-1-one, used as antiarrhythmic agents |
03/22/2005 | US6870052 Preparation of thioarabinofuranosyl compounds and use thereof |
03/22/2005 | US6869973 Nitrosated and nitrosylated taxanes, compositions and methods of use |
03/22/2005 | US6869969 Isoxazole estrogen receptor agonist and antagonist |
03/22/2005 | US6869957 Non-peptide tachykinin receptor antagonists |
03/22/2005 | US6869953 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents |
03/22/2005 | US6869950 Such as 1-(2-chloro-4-(n-octyloxy)benzyl)-2-methyl-6-(1-pentane -sulfonylcarbamoyl)benzimidazole |
03/22/2005 | US6869943 Sorbitol dehydrogenase inhibitors |
03/22/2005 | US6869696 Organic red electro-luminescent device including a heterocyclic emitter |
03/17/2005 | WO2005024440A2 Polarizing agents for dynamic nuclear polarization |
03/17/2005 | WO2005023818A2 Heterobicyclic compounds as pharmaceutically active agents |
03/17/2005 | WO2005023800A1 Halo substituted benzo`b! thiophenes with pi3k inhibitory activity as therapeutic agents |
03/17/2005 | WO2005023799A1 Fused bicyclic carboxamide derivatives and methods of their use |
03/17/2005 | WO2005023794A2 Compound libraries of 4-carboxamidopiperidine derivatives |
03/17/2005 | WO2005023773A1 Process for the preparation of substituted aryl pyrazoles |
03/17/2005 | WO2005023261A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
03/17/2005 | WO2005023246A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp) |
03/17/2005 | WO2005005415A8 Indoles useful in the treatment of inflammation |
03/17/2005 | WO2004092196A3 Tie-2 modulators and methods of use |
03/17/2005 | WO2004074270B1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
03/17/2005 | WO2003053959A8 Heterocyclylamino carbonyluracils |
03/17/2005 | WO2003045918A8 Piperidine-based mch antagonists for treatment of obesity and cns disorders |
03/17/2005 | WO2002072571A8 Pyridinyl pyrazoles useful for the treatment of copd |
03/17/2005 | US20050059823 quinazolinone compounds such as 2-cyclopropyl-4-oxo-3-((p-fluorobenzyl)carbonylamino)-7-fluoro-1,2-dihydroquinazoline; brain and nervous system disorders such as mood disorders or neuropathic pain |
03/17/2005 | US20050059729 Substituted cyclic compounds |
03/17/2005 | US20050059726 For treating thrombosis and factor xa-related cardiovascular and neurodegenerative diseases; 6-Chloro-N-{(3S)-1-[3-fluoro-2'-(methylsulfonyl)-1,1'-biphenyl-4-yl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide for example |
03/17/2005 | US20050059722 Kinase inhibitors, such as focal adhesion kinase (FAK) inhibitors; treating cancer; 2-methylsulfonyl-N-(3-thiophen-2-yl-1H-indazol-5-yl)benzenesulfonamide for example |
03/17/2005 | US20050059712 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma |
03/17/2005 | US20050059702 Elevate the progenitor and/or stem cell population in peripheral blood or bone marrow; treatment of HIV, inflammatory condition like rheumatoid arthritis, tumor, asthma; 4-(3,3''-Dimethyl-3',4',5',6'-tetrahydro-2'H-cis-[2,2';6',2'']terpyridin-1'-yl-butylamine |
03/17/2005 | US20050059687 Modulators of ATP-Binding Cassette transporters |
03/17/2005 | US20050059678 such as (E)-N-{4-[4-(benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide used as antineoplastic agents, or inhibitors of the HER-2 gene or proteins and epidermal growth factor receptor enzymes |
03/17/2005 | US20050059673 serotonin receptor antagonists such as 8-{4-[2-(1-benzofuran-3-yl)ethyl]-1-piperazinyl}-6-fluoroquinoline, used for treatment and/or prevention of depression, anxiety and cognitive deficits arising from Alzheimer's disease, neurodegenerative disorders, schizophrenia and prostate cancer |
03/17/2005 | US20050059668 Substituted acylpiperazine derivatives |
03/17/2005 | US20050059666 CCR5 antagonists useful for treating AIDS |
03/17/2005 | US20050059663 4-{3-[4-(6-Chlorobenzothiazol-2-yl)-1,4-diazepan-1-ylcarbonyl]benzyl}-1(2H)-phthalazinone; Cancer, BRCA deficient |
03/17/2005 | US20050058917 Charge transport compound containing at least two carbazolecarboxaldehyde substituted- hydrazone groups |
03/17/2005 | US20050058635 Anticancer agents; therapy for infections; administering glutaminyl cyclase inhibitor; Alzheimer's disease; Down syndrome; controlling fertility; schizophrenia; skin disorders |
03/17/2005 | US20050056293 Reduced ignition propensity smoking article |
03/17/2005 | DE10306502B4 Substituierte 3-(Benzoylureido)-thiophenderivate und sie enthaltende Arzneimittel Substituted 3- (Benzoylureido) -thiophenderivate and medicaments containing them |
03/17/2005 | CA2577909A1 Polarizing agents for dynamic nuclear polarization |
03/17/2005 | CA2572750A1 Heterobicyclic compounds as pharmaceutically active agents |
03/17/2005 | CA2538135A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
03/17/2005 | CA2537097A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp) |
03/17/2005 | CA2536967A1 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
03/17/2005 | CA2536930A1 Halo substituted benzo`b! thiophenes with pi3k inhibitory activity as therapeutic agents |
03/16/2005 | EP1513911A1 Phosphorescent and luminescent conjugated polymers and their use in electroluminescent assemblies |
03/16/2005 | EP1513834A1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
03/16/2005 | EP1513830A1 Bisindolyl-maleimid derivatives as kinase inhibitors |
03/16/2005 | EP1513828A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders |
03/16/2005 | EP1513814A1 Novel piperidine compound |
03/16/2005 | EP1513809A1 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders |
03/16/2005 | EP1513796A2 Phenyloxyalkanoic acid derivatives as hppar activators |
03/16/2005 | EP1513530A1 Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex |
03/16/2005 | EP1513520A2 Substituted pyrrolines as kinase inhibitors |
03/16/2005 | EP1399436B1 Oxytocin agonists |
03/16/2005 | EP1355903B1 Pyrazole derivatives against tgf overexpression |
03/16/2005 | EP1250047B1 Herbicidal composition |
03/16/2005 | EP1049664B1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
03/16/2005 | EP0758324B1 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
03/16/2005 | CN1596250A Paclitaxel solvates |
03/16/2005 | CN1596240A Chalcone derivatives and their use to treat diseases |
03/16/2005 | CN1596114A Substituted 1, 4-benzodiazepines and uses thereof for the treatment of cancer |
03/16/2005 | CN1193027C Substituted pyrroles |